Published On: Wed, Oct 19th, 2016

Latest Analyst Reports On Mindray Medical International Limited


Recently stock market analysts have updated their consensus ratings on shares of Mindray Medical International Limited (NYSE:MR).

Most recent broker ratings

11/13/2015 – Mindray Medical International Limited had its “hold” rating reiterated by analysts at Standpoint Research.

10/26/2015 – Mindray Medical International Limited was downgraded to “hold” by analysts at Deutsche Bank. They now have a USD 27 price target on the stock.

06/08/2015 – Mindray Medical International Limited was upgraded to “market perform” by analysts at JMP Securities. They now have a USD 30 price target on the stock.

05/18/2015 – Mindray Medical International Limited was downgraded to “strong sell” by analysts at Zacks.

03/11/2015 – Mindray Medical International Limited was downgraded to “underperform” by analysts at Credit Suisse.

12/12/2014 – Mindray Medical International Limited was downgraded to “underweight” by analysts at Morgan Stanley. They now have a USD 28 price target on the stock.

08/13/2014 – Mindray Medical International Limited had its “hold” rating reiterated by analysts at Jefferies. They now have a USD 29 price target on the stock.

05/07/2014 – Mindray Medical International Limited was downgraded to “neutral” by analysts at Bank of America Merrill Lynch. They now have a USD 34 price target on the stock.

03/05/2014 – Mindray Medical International Limited had its “outperform” rating reiterated by analysts at Oppenheimer. They now have a USD 42 price target on the stock.

Mindray Medical International Limited has a 50 day moving average of 27.20 and a 200 day moving average of 25.81. It has a 52-week low of 21.80 and a 52-week high of 33.83.

The share price of the company (NYSE:MR) was up +0.00%, with a high of 0.00 during the day and the volume of Mindray Medical International Limited shares traded was 0.

Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature. It offers patient monitoring devices that are suitable for adult, pediatric and neonatal patients and are used principally in hospital intensive care units, operating rooms and emergency rooms. Its life support products provide operation room or intensive care unit solutions for the end users in the operating room. Its in-vitro diagnostic products provide data and analysis on blood, urine and other bodily fluid samples for clinical diagnosis and treatment. Its medical imaging systems segment includes ultrasound systems, digital radiography systems and a magnetic resonance imaging system.